Comprehensive expertise with biotech customers across phases and around the world
2
%
Phase IV
30
%
Phase III
34
%
Phase II
34
%
Phase I
Trial Expertise by Phase
Expertise running trials in
*Studies conducted in the last five years
Comprehensive expertise with biotech customers across phases and around the world
*Studies conducted in the last five years
2
%
Phase IV
30
%
Phase III
34
%
Phase II
34
%
Phase I
Trial Expertise by Phase
Expertise running trials in
74
countries
74
countries